Currently, out of the existing stock ratings of Mara Goldstein - 105 which are a Buy (72.41%), 39 which are a Hold (26.9%), 1 which are a Sell (0.69%)

Mara Goldstein

Work Performance Price Targets & Ratings Chart

Analyst Mara Goldstein works at MIZUHO and is covering Healthcare, Communication Services sectors with 256 price targets and ratings displayed on 32 stocks. Previously, Mara Goldstein worked at CANTOR FITZGERALD.

Mara Goldstein's average stock forecast success ratio is 43.77% with an average time for price targets to be met of 207 days.

Most recent stock forecast was given on FATE, Fate Therapeutics at 20-Nov-2023.

Wall Street Analyst Mara Goldstein

Analyst best performing recommendations are on FTSV.
The best stock recommendation documented was for VSTM (VERASTEM) at 3/30/2023. The price target of $2 was fulfilled within 63 days with a profit of $1.6 (400%) receiving and performance score of 63.49.

Average potential price target upside

of $53.72 (57.98%) on SNSS.
of $26.43 (35.53%) on LUMO (LUMOS PHARMA).
of $26.43 (35.53%) on NLNK.

CELG CLDX Celldex Therapeutics CRVS Corvus Pharmaceuticals CTMX CytomX Therapeutics FATE Fate Therapeutics FTSV IMGN ImmunoGen INCY yte KDMN MRK Merck . NLNK RDUS Radius Health RLYP TC TuanChe AGTC Applied Genetic Technologies IOVA Iovance Biotherapeutics RCUS Arcus Biosciences SNSS EFTR LUMO Lumos Pharma NKTR Nektar Therapeutics SGEN Seattle Genetics LPTX ADAP Adaptimmune Therapeutics plc NLTX ARDX Ardelyx AUTL ERAS IMRX TCRR TCR2 Therapeutics VSTM Verastem XNCR Xencor

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Brian Skorney (BAIRD)